It is suggested that the biomarkers of Th2 inflammation such as IgE, peripheral blood, or induced sputum eosinophils, FeNO, and osteochondral proteins may be used to guide biologically targeted therapies for asthma [17,18]. Here, IGHE is linked to asthma.